Europe Organ-on-Chip Market

Europe Organ-on-Chip Market size was valued at USD 50 million in 2025 and is forecast to grow from USD 60.7 million in 2026 to reach USD 162.0 million by 2031, at a CAGR of 26.5%.

Description

The Europe Organ-on-Chip Market size was valued at USD 50 million in 2025 and is forecast to grow from USD 60.7 million in 2026 to reach USD 162.0 million by 2031, at a CAGR of 26.5%. Organ-on-chip technology consists of micro-engineered devices that place living human cells within continuously perfused, three-dimensional microchannels, recreating key physiological functions of human organs on a transparent chip to replicate tissue interfaces, mechanical forces, and dynamic biological processes without relying on animal testing. The market sits at the intersection of microfluidics, tissue engineering, and pharmaceutical R&D innovation, making it one of the most closely watched enabling technologies across the regional drug-development and precision-medicine value chain.

Demand for organ-on-chip platforms remains anchored by pharmaceutical companies redirecting R&D funds toward animal-free testing methods, regulatory validation of microphysiological systems, and growing academic-industry collaboration across Germany, the United Kingdom, France, and the Netherlands. Beyond drug discovery, organ-on-chip technology continues to enable applications in disease modeling, toxicology testing, and personalized-medicine research that require precise, human-relevant biological simulation. Rising biopharmaceutical R&D expenditure, supportive European standardization roadmaps that ease cross-border adoption, and continued advances in multi-organ chip integration are sustaining consumption even as the region transitions from academic research toward broader pharmaceutical-industry validation.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Organ-on-Chip Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component (Products, Services)

      2. By Application (Drug Discovery & Development, Disease Modeling, Toxicology Testing, Personalized Medicine, Others)

      3. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Organ-on-Chip Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • United Kingdom Organ-on-Chip Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • France Organ-on-Chip Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • Netherlands Organ-on-Chip Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • Rest of Europe Organ-on-Chip Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Organ-on-Chip Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Emulate, Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. CN Bio Innovations Ltd.

    3. TissUse GmbH

    4. Mimetas B.V.

    5. AlveoliX AG

    6. Hesperos, Inc.

    7. InSphero AG

    8. Nortis, Inc.

    9. Draper Laboratory

    10. AxoSim, Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology